#ID(s) interactor A	ID(s) interactor B	Alt. ID(s) interactor A	Alt. ID(s) interactor B	Alias(es) interactor A	Alias(es) interactor B	Interaction detection method(s)	Publication 1st author(s)	Publication Identifier(s)	Taxid interactor A	Taxid interactor B	Interaction type(s)	Source database(s)	Interaction identifier(s)	Confidence value(s)	Expansion method(s)	Biological role(s) interactor A	Biological role(s) interactor B	Experimental role(s) interactor A	Experimental role(s) interactor B	Type(s) interactor A	Type(s) interactor B	Xref(s) interactor A	Xref(s) interactor B	Interaction Xref(s)	Annotation(s) interactor A	Annotation(s) interactor B	Interaction annotation(s)	Host organism(s)	Interaction parameter(s)	Creation date	Update date	Checksum(s) interactor A	Checksum(s) interactor B	Interaction Checksum(s)	Negative	Feature(s) interactor A	Feature(s) interactor B	Stoichiometry(s) interactor A	Stoichiometry(s) interactor B	Identification method participant A	Identification method participant B
uniprotkb:O43405	uniprotkb:P02452	intact:EBI-8493486|ensembl:ENSP00000379862|ensembl:ENSP00000494838|ensembl:ENSP00000496360|uniprotkb:A8K9K9|intact:UNK-5359533|uniprotkb:D3DS84|uniprotkb:Q96IU6	intact:EBI-982999|uniprotkb:O76045|uniprotkb:P78441|uniprotkb:Q13896|uniprotkb:Q13902|uniprotkb:Q13903|uniprotkb:Q14037|uniprotkb:Q14992|uniprotkb:Q15176|uniprotkb:Q15201|uniprotkb:Q16050|uniprotkb:Q59F64|uniprotkb:Q7KZ30|uniprotkb:Q7KZ34|uniprotkb:Q8IVI5|ensembl:ENSP00000225964|uniprotkb:Q8N473|uniprotkb:Q9UML6|uniprotkb:Q9UMM7	psi-mi:coch_human(display_long)|uniprotkb:COCH(gene name)|psi-mi:COCH(display_short)|uniprotkb:COCH5B2(gene name synonym)|uniprotkb:UNQ257/PRO294(orf name)|uniprotkb:COCH-5B2(gene name synonym)	psi-mi:co1a1_human(display_long)|uniprotkb:Alpha-1 type I collagen(gene name synonym)|uniprotkb:COL1A1(gene name)|psi-mi:COL1A1(display_short)	psi-mi:"MI:0107"(surface plasmon resonance)	Nagy et al. (2008)	pubmed:19013156|imex:IM-9582|mint:MINT-6796043|doi:10.1016/j.febslet.2008.10.050|mint:d-08-01973	taxid:9606(human)|taxid:9606(Homo sapiens)	taxid:9606(human)|taxid:9606(Homo sapiens)	psi-mi:"MI:0407"(direct interaction)	psi-mi:"MI:0471"(MINT)	intact:EBI-8493479|mint:MINT-6796048|imex:IM-9582-1	-	-	psi-mi:"MI:0499"(unspecified role)	psi-mi:"MI:0499"(unspecified role)	psi-mi:"MI:0498"(prey)	psi-mi:"MI:0496"(bait)	psi-mi:"MI:0326"(protein)	psi-mi:"MI:0326"(protein)	ensembl:ENSG00000100473(gene)|ensembl:ENST00000396618(transcript)|ensembl:ENST00000643575(transcript)|ensembl:ENST00000644874(transcript)|go:"GO:0005518"(collagen binding)|go:"GO:0005576"(extracellular region)|go:"GO:0007605"(sensory perception of sound)|go:"GO:0008360"(regulation of cell shape)|go:"GO:0042742"(defense response to bacterium)|go:"GO:0045089"(positive regulation of innate immune response)|go:"GO:0062023"(collagen-containing extracellular matrix)|interpro:IPR002035(von Willebrand factor, type A)|interpro:IPR004043(LCCL)|interpro:IPR030743|interpro:IPR036465|interpro:IPR036609|mint:O43405|rcsb pdb:1JBI|refseq:NP_001128530.1|refseq:NP_004077.1|mint:MINT-6796050(identity)	refseq:NP_000079.2|ensembl:ENSG00000108821(gene)|ensembl:ENST00000225964(transcript)|go:"GO:0001501"(skeletal system development)|go:"GO:0001503"(ossification)|go:"GO:0001568"(blood vessel development)|go:"GO:0001649"(osteoblast differentiation)|go:"GO:0001957"(intramembranous ossification)|go:"GO:0001958"(endochondral ossification)|go:"GO:0002020"(protease binding)|go:"GO:0005201"(extracellular matrix structural constituent)|go:"GO:0005576"(extracellular region)|go:"GO:0005584"(collagen type I trimer)|go:"GO:0005615"(extracellular space)|go:"GO:0005737"(cytoplasm)|go:"GO:0005788"(endoplasmic reticulum lumen)|go:"GO:0005794"(Golgi apparatus)|go:"GO:0007601"(visual perception)|go:"GO:0007605"(sensory perception of sound)|go:"GO:0009612"(response to mechanical stimulus)|go:"GO:0010718"(positive regulation of epithelial to mesenchymal transition)|go:"GO:0010812"(negative regulation of cell-substrate adhesion)|go:"GO:0015031"(protein transport)|go:"GO:0030020"(extracellular matrix structural constituent conferring tensile strength)|go:"GO:0030141"(secretory granule)|go:"GO:0030198"(extracellular matrix organization)|go:"GO:0030199"(collagen fibril organization)|go:"GO:0030335"(positive regulation of cell migration)|go:"GO:0031012"(extracellular matrix)|go:"GO:0031960"(response to corticosteroid)|go:"GO:0032355"(response to estradiol)|go:"GO:0032964"(collagen biosynthetic process)|go:"GO:0034504"(protein localization to nucleus)|go:"GO:0034505"(tooth mineralization)|go:"GO:0038063"(collagen-activated tyrosine kinase receptor signaling pathway)|go:"GO:0042060"(wound healing)|go:"GO:0042493"|go:"GO:0042542"(response to hydrogen peroxide)|go:"GO:0042802"(identical protein binding)|go:"GO:0043434"(response to peptide hormone)|go:"GO:0043588"(skin development)|go:"GO:0043589"(skin morphogenesis)|go:"GO:0044344"(cellular response to fibroblast growth factor stimulus)|go:"GO:0044691"(tooth eruption)|go:"GO:0046872"(metal ion binding)|go:"GO:0048407"(platelet-derived growth factor binding)|go:"GO:0048706"(embryonic skeletal system development)|go:"GO:0051591"(response to cAMP)|go:"GO:0055093"(response to hyperoxia)|go:"GO:0060325"(face morphogenesis)|go:"GO:0060346"(bone trabecula formation)|go:"GO:0060351"(cartilage development involved in endochondral bone morphogenesis)|go:"GO:0062023"(collagen-containing extracellular matrix)|go:"GO:0071230"(cellular response to amino acid stimulus)|go:"GO:0071260"(cellular response to mechanical stimulus)|go:"GO:0071300"(cellular response to retinoic acid)|go:"GO:0071306"(cellular response to vitamin E)|go:"GO:0071356"(cellular response to tumor necrosis factor)|go:"GO:0045893"(positive regulation of transcription, DNA-templated)|go:"GO:0071364"(cellular response to epidermal growth factor stimulus)|go:"GO:0090263"(positive regulation of canonical Wnt signaling pathway)|go:"GO:1902618"(cellular response to fluoride)|interpro:IPR000885(Fibrillar collagen, C-terminal)|interpro:IPR001007(von Willebrand factor, type C)|interpro:IPR008160(Collagen triple helix repeat)|mint:P02452|rcsb pdb:1Q7D|rcsb pdb:2LLP|rcsb pdb:3EJH|rcsb pdb:3GXE|rcsb pdb:5CTD|rcsb pdb:5CTI|rcsb pdb:5CVA|rcsb pdb:5CVB|rcsb pdb:5K31|rcsb pdb:5OU8|go:"GO:0071560"(cellular response to transforming growth factor beta stimulus)|rcsb pdb:5OU9|rcsb pdb:7E7B|rcsb pdb:7E7D|reactome:R-HSA-114604|reactome:R-HSA-1442490|reactome:R-HSA-1474244|reactome:R-HSA-1650814|reactome:R-HSA-198933|reactome:R-HSA-2022090|reactome:R-HSA-202733|reactome:R-HSA-216083|reactome:R-HSA-2214320|reactome:R-HSA-2243919|reactome:R-HSA-3000170|reactome:R-HSA-3000171|reactome:R-HSA-3000178|reactome:R-HSA-3000480|reactome:R-HSA-430116|reactome:R-HSA-75892|reactome:R-HSA-76009|reactome:R-HSA-8874081|reactome:R-HSA-8940973|reactome:R-HSA-8948216|dip:DIP-36077N|mint:MINT-6796051(identity)	-	comment:mint|function:"Defects in COCH are the cause of non-syndromic sensorineural deafness autosomal dominant type 9 (DFNA9) [MIM:601369]. DFNA9 is a form of sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information. DFNA9 is characterized by onset in the fourth or fifth decade of life and initially involves the high frequencies. Deafness is progressive and usually complete by the sixth decade. In addition to cochlear involvement, DFNA9 patients also exhibit a spectrum of vestibular dysfunctions. Penetrance of the vestibular symptoms is often incomplete, and some patients are minimally affected, whereas others suffer from severe balance disturbances and episodes of vertigo. Affected individuals have mucopolysaccharide depositions in the channels of the cochlear and vestibular nerves. These depositions apparently cause strangulation and degeneration of dendritic fibers"|function:"Defects in COCH may contribute to Meniere disease [MIM:156000]. Meniere disease is an autosomal dominant disorder characterized by hearing loss associated with episodic vertigo. Antibodies against COCH are found in 10% of Meniere patients"	-	figure legend:F2A|comment:homomint|comment:mint|full coverage:Only protein-protein interactions|curation depth:imex curation	taxid:-1(in vitro)|taxid:-1(In vitro)	kd:7.97x10^-8(molar)	2008/11/05	2014/10/16	rogid:lY0jFedFr6Xbs17fSnCfnGJzLMY9606	rogid:x83+B64Cl9zkAVeZ9RCo0BukkwU9606	intact-crc:D94B63D038141604|rigid:IAQgA8B4LIbQ6QOJVzzYRF3/3lQ	false	binding-associated region:367-537(MINT-6796056)|his tag:?-?(MINT-6796053)	-	-	-	psi-mi:"MI:0396"(predetermined participant)	psi-mi:"MI:0396"(predetermined participant)
uniprotkb:O43405	uniprotkb:P02462	intact:EBI-8493486|ensembl:ENSP00000379862|ensembl:ENSP00000494838|ensembl:ENSP00000496360|uniprotkb:A8K9K9|intact:UNK-5359533|uniprotkb:D3DS84|uniprotkb:Q96IU6	intact:EBI-2432478|uniprotkb:B1AM70|uniprotkb:A7E2W4|uniprotkb:Q1P9S9|uniprotkb:Q5VWF6|uniprotkb:Q86X41|uniprotkb:Q8NF88|uniprotkb:Q9NYC5|uniprotkb:F5H5K0|ensembl:ENSP00000364979	psi-mi:coch_human(display_long)|uniprotkb:COCH(gene name)|psi-mi:COCH(display_short)|uniprotkb:COCH5B2(gene name synonym)|uniprotkb:UNQ257/PRO294(orf name)|uniprotkb:COCH-5B2(gene name synonym)	psi-mi:co4a1_human(display_long)|uniprotkb:COL4A1(gene name)|psi-mi:COL4A1(display_short)	psi-mi:"MI:0107"(surface plasmon resonance)	Nagy et al. (2008)	pubmed:19013156|imex:IM-9582|mint:MINT-6796043|doi:10.1016/j.febslet.2008.10.050|mint:d-08-01973	taxid:9606(human)|taxid:9606(Homo sapiens)	taxid:9606(human)|taxid:9606(Homo sapiens)	psi-mi:"MI:0407"(direct interaction)	psi-mi:"MI:0471"(MINT)	intact:EBI-8493695|mint:MINT-6796166|imex:IM-9582-3	-	-	psi-mi:"MI:0499"(unspecified role)	psi-mi:"MI:0499"(unspecified role)	psi-mi:"MI:0498"(prey)	psi-mi:"MI:0496"(bait)	psi-mi:"MI:0326"(protein)	psi-mi:"MI:0326"(protein)	ensembl:ENSG00000100473(gene)|ensembl:ENST00000396618(transcript)|ensembl:ENST00000643575(transcript)|ensembl:ENST00000644874(transcript)|go:"GO:0005518"(collagen binding)|go:"GO:0005576"(extracellular region)|go:"GO:0007605"(sensory perception of sound)|go:"GO:0008360"(regulation of cell shape)|go:"GO:0042742"(defense response to bacterium)|go:"GO:0045089"(positive regulation of innate immune response)|go:"GO:0062023"(collagen-containing extracellular matrix)|interpro:IPR002035(von Willebrand factor, type A)|interpro:IPR004043(LCCL)|interpro:IPR030743|interpro:IPR036465|interpro:IPR036609|mint:O43405|rcsb pdb:1JBI|refseq:NP_001128530.1|refseq:NP_004077.1|mint:MINT-6796170(identity)	refseq:NP_001290039.1|refseq:NP_001836.3|ensembl:ENSG00000187498(gene)|ensembl:ENST00000375820(transcript)|go:"GO:0001569"(branching involved in blood vessel morphogenesis)|go:"GO:0005201"(extracellular matrix structural constituent)|go:"GO:0005576"(extracellular region)|go:"GO:0005587"(collagen type IV trimer)|go:"GO:0005604"(basement membrane)|go:"GO:0005615"(extracellular space)|go:"GO:0005788"(endoplasmic reticulum lumen)|go:"GO:0007420"(brain development)|go:"GO:0007528"(neuromuscular junction development)|go:"GO:0030020"(extracellular matrix structural constituent conferring tensile strength)|go:"GO:0030198"(extracellular matrix organization)|go:"GO:0030855"(epithelial cell differentiation)|go:"GO:0031012"(extracellular matrix)|go:"GO:0038063"(collagen-activated tyrosine kinase receptor signaling pathway)|go:"GO:0048407"(platelet-derived growth factor binding)|go:"GO:0048514"(blood vessel morphogenesis)|go:"GO:0061304"(retinal blood vessel morphogenesis)|go:"GO:0061333"(renal tubule morphogenesis)|go:"GO:0062023"(collagen-containing extracellular matrix)|go:"GO:0071230"(cellular response to amino acid stimulus)|go:"GO:0071711"(basement membrane organization)|interpro:IPR001442(Type 4 procollagen, C-terminal repeat)|interpro:IPR008160(Collagen triple helix repeat)|interpro:IPR016187(C-type lectin fold)|interpro:IPR036954|mint:P02462|rcsb pdb:1LI1|rcsb pdb:5NAX|rcsb pdb:5NAY|rcsb pdb:6MPX|reactome:R-HSA-1442490|reactome:R-HSA-1474244|reactome:R-HSA-1650814|reactome:R-HSA-186797|reactome:R-HSA-2022090|reactome:R-HSA-216083|reactome:R-HSA-2214320|reactome:R-HSA-2243919|reactome:R-HSA-3000157|reactome:R-HSA-3000171|reactome:R-HSA-3000178|reactome:R-HSA-3000480|reactome:R-HSA-419037|reactome:R-HSA-8948216|mint:MINT-6796168(identity)	-	comment:mint|function:"Defects in COCH are the cause of non-syndromic sensorineural deafness autosomal dominant type 9 (DFNA9) [MIM:601369]. DFNA9 is a form of sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information. DFNA9 is characterized by onset in the fourth or fifth decade of life and initially involves the high frequencies. Deafness is progressive and usually complete by the sixth decade. In addition to cochlear involvement, DFNA9 patients also exhibit a spectrum of vestibular dysfunctions. Penetrance of the vestibular symptoms is often incomplete, and some patients are minimally affected, whereas others suffer from severe balance disturbances and episodes of vertigo. Affected individuals have mucopolysaccharide depositions in the channels of the cochlear and vestibular nerves. These depositions apparently cause strangulation and degeneration of dendritic fibers"|function:"Defects in COCH may contribute to Meniere disease [MIM:156000]. Meniere disease is an autosomal dominant disorder characterized by hearing loss associated with episodic vertigo. Antibodies against COCH are found in 10% of Meniere patients"	-	figure legend:F2C|comment:homomint|comment:mint|full coverage:Only protein-protein interactions|curation depth:imex curation	taxid:-1(in vitro)|taxid:-1(In vitro)	kd:1.1x10^-7(molar)	2008/11/05	2018/06/01	rogid:lY0jFedFr6Xbs17fSnCfnGJzLMY9606	rogid:/U3Xsl1lPZnPBfd1cRVDqtuvVb49606	intact-crc:7EAF94D99ED9101A|rigid:PPhNYsRUQHYPOnuociV+YVtPyig	false	his tag:?-?(MINT-6796171)|binding-associated region:367-537(MINT-6796173)	-	-	-	psi-mi:"MI:0396"(predetermined participant)	psi-mi:"MI:0396"(predetermined participant)
uniprotkb:O43405	uniprotkb:P02458	intact:EBI-8493486|ensembl:ENSP00000379862|ensembl:ENSP00000494838|ensembl:ENSP00000496360|uniprotkb:A8K9K9|intact:UNK-5359533|uniprotkb:D3DS84|uniprotkb:Q96IU6	intact:EBI-2431412|uniprotkb:A6NGA0|uniprotkb:Q14047|uniprotkb:Q14056|uniprotkb:Q14058|uniprotkb:Q16672|uniprotkb:Q1JQ82|uniprotkb:Q12985|uniprotkb:Q14009|uniprotkb:Q14044|uniprotkb:Q14045|uniprotkb:Q14046|uniprotkb:Q9UE41|uniprotkb:Q9UE42|uniprotkb:Q9UE43|uniprotkb:Q6LBY2|uniprotkb:Q6LBY3|uniprotkb:Q96IT5|uniprotkb:Q99227|uniprotkb:Q9UE38|uniprotkb:Q9UE39|uniprotkb:Q9UE40|uniprotkb:Q2V4X7|uniprotkb:Q6LBY1|ensembl:ENSP00000369889	psi-mi:coch_human(display_long)|uniprotkb:COCH(gene name)|psi-mi:COCH(display_short)|uniprotkb:COCH5B2(gene name synonym)|uniprotkb:UNQ257/PRO294(orf name)|uniprotkb:COCH-5B2(gene name synonym)	psi-mi:co2a1_human(display_long)|uniprotkb:COL2A1(gene name)|psi-mi:COL2A1(display_short)|uniprotkb:Alpha-1 type II collagen(gene name synonym)	psi-mi:"MI:0107"(surface plasmon resonance)	Nagy et al. (2008)	pubmed:19013156|imex:IM-9582|mint:MINT-6796043|doi:10.1016/j.febslet.2008.10.050|mint:d-08-01973	taxid:9606(human)|taxid:9606(Homo sapiens)	taxid:9606(human)|taxid:9606(Homo sapiens)	psi-mi:"MI:0407"(direct interaction)	psi-mi:"MI:0471"(MINT)	intact:EBI-8493661|mint:MINT-6796062|imex:IM-9582-2	-	-	psi-mi:"MI:0499"(unspecified role)	psi-mi:"MI:0499"(unspecified role)	psi-mi:"MI:0498"(prey)	psi-mi:"MI:0496"(bait)	psi-mi:"MI:0326"(protein)	psi-mi:"MI:0326"(protein)	ensembl:ENSG00000100473(gene)|ensembl:ENST00000396618(transcript)|ensembl:ENST00000643575(transcript)|ensembl:ENST00000644874(transcript)|go:"GO:0005518"(collagen binding)|go:"GO:0005576"(extracellular region)|go:"GO:0007605"(sensory perception of sound)|go:"GO:0008360"(regulation of cell shape)|go:"GO:0042742"(defense response to bacterium)|go:"GO:0045089"(positive regulation of innate immune response)|go:"GO:0062023"(collagen-containing extracellular matrix)|interpro:IPR002035(von Willebrand factor, type A)|interpro:IPR004043(LCCL)|interpro:IPR030743|interpro:IPR036465|interpro:IPR036609|mint:O43405|rcsb pdb:1JBI|refseq:NP_001128530.1|refseq:NP_004077.1|mint:MINT-6796066(identity)	refseq:NP_001835.3|refseq:NP_149162.2|ensembl:ENSG00000139219(gene)|ensembl:ENST00000380518(transcript)|go:"GO:0001501"(skeletal system development)|go:"GO:0001502"(cartilage condensation)|go:"GO:0001894"(tissue homeostasis)|go:"GO:0001958"(endochondral ossification)|go:"GO:0002062"(chondrocyte differentiation)|go:"GO:0003007"(heart morphogenesis)|go:"GO:0005201"(extracellular matrix structural constituent)|go:"GO:0005576"(extracellular region)|go:"GO:0005581"(collagen trimer)|go:"GO:0005585"(collagen type II trimer)|go:"GO:0005604"(basement membrane)|go:"GO:0005615"(extracellular space)|go:"GO:0005788"(endoplasmic reticulum lumen)|go:"GO:0006029"(proteoglycan metabolic process)|go:"GO:0007417"(central nervous system development)|go:"GO:0007601"(visual perception)|go:"GO:0007605"(sensory perception of sound)|go:"GO:0010468"(regulation of gene expression)|go:"GO:0030198"(extracellular matrix organization)|go:"GO:0030199"(collagen fibril organization)|go:"GO:0030903"(notochord development)|go:"GO:0031012"(extracellular matrix)|go:"GO:0042289"(MHC class II protein binding)|go:"GO:0042472"(inner ear morphogenesis)|go:"GO:0042802"(identical protein binding)|go:"GO:0043394"(proteoglycan binding)|go:"GO:0046872"(metal ion binding)|go:"GO:0048407"(platelet-derived growth factor binding)|go:"GO:0051216"(cartilage development)|go:"GO:0060021"(roof of mouth development)|go:"GO:0060174"(limb bud formation)|go:"GO:0060272"(embryonic skeletal joint morphogenesis)|go:"GO:0060351"(cartilage development involved in endochondral bone morphogenesis)|go:"GO:0062023"(collagen-containing extracellular matrix)|go:"GO:0071599"(otic vesicle development)|go:"GO:0071773"(cellular response to BMP stimulus)|go:"GO:0097065"(anterior head development)|go:"GO:2001240"(negative regulation of extrinsic apoptotic signaling pathway in absence of ligand)|interpro:IPR000885(Fibrillar collagen, C-terminal)|interpro:IPR001007(von Willebrand factor, type C)|interpro:IPR008160(Collagen triple helix repeat)|mint:P02458|rcsb pdb:1U5M|rcsb pdb:2FSE|rcsb pdb:2SEB|rcsb pdb:5NIR|rcsb pdb:5OCX|rcsb pdb:5OCY|rcsb pdb:6BIN|rcsb pdb:6NIX|reactome:R-HSA-1442490|reactome:R-HSA-1474244|reactome:R-HSA-1650814|reactome:R-HSA-186797|reactome:R-HSA-198933|reactome:R-HSA-2022090|reactome:R-HSA-216083|reactome:R-HSA-3000171|reactome:R-HSA-3000178|reactome:R-HSA-419037|reactome:R-HSA-8874081|reactome:R-HSA-8948216|go:"GO:0030020"(extracellular matrix structural constituent conferring tensile strength)|mint:MINT-6796064(identity)	-	comment:mint|function:"Defects in COCH are the cause of non-syndromic sensorineural deafness autosomal dominant type 9 (DFNA9) [MIM:601369]. DFNA9 is a form of sensorineural hearing loss. Sensorineural deafness results from damage to the neural receptors of the inner ear, the nerve pathways to the brain, or the area of the brain that receives sound information. DFNA9 is characterized by onset in the fourth or fifth decade of life and initially involves the high frequencies. Deafness is progressive and usually complete by the sixth decade. In addition to cochlear involvement, DFNA9 patients also exhibit a spectrum of vestibular dysfunctions. Penetrance of the vestibular symptoms is often incomplete, and some patients are minimally affected, whereas others suffer from severe balance disturbances and episodes of vertigo. Affected individuals have mucopolysaccharide depositions in the channels of the cochlear and vestibular nerves. These depositions apparently cause strangulation and degeneration of dendritic fibers"|function:"Defects in COCH may contribute to Meniere disease [MIM:156000]. Meniere disease is an autosomal dominant disorder characterized by hearing loss associated with episodic vertigo. Antibodies against COCH are found in 10% of Meniere patients"	-	figure legend:F2B|comment:homomint|comment:mint|full coverage:Only protein-protein interactions|curation depth:imex curation	taxid:-1(in vitro)|taxid:-1(In vitro)	kd:9.45x10^-8(molar)	2008/11/05	2014/10/16	rogid:lY0jFedFr6Xbs17fSnCfnGJzLMY9606	rogid:T3mQ7b4d6vjE0vl3Kaa09PdldN89606	intact-crc:96F97C9FA3D00771|rigid:N8/RwJ3VoNg+kLI+AKIPyewWHWs	false	binding-associated region:367-537(MINT-6796067)|his tag:?-?(MINT-6796070)	-	-	-	psi-mi:"MI:0396"(predetermined participant)	psi-mi:"MI:0396"(predetermined participant)